COSCIENS Biopharma Inc (0UGB)

London


Symbol	Exchange	Currency
CSCI	Toronto	CAD	Real-time
CSCI	NASDAQ	USD	Real-time
0UGB	London	CAD	Real-time
ET8	Frankfurt	EUR	Delayed

Currency in CAD

Disclaimer

5.01

0.00(0.00%)

Real-time Data29/08

Fair Value

Unlock Value

Day's Range

5.01

52 wk Range

5.01

10.05

0UGB Cash Flow Statement
Featured here, the Cash Flow Statement for COSCIENS Biopharma Inc, showing the changes in the company's cash and cash equivalents, broken down to operating, investing and financing activities over each of the last 10 periods (either quarterly or annually).

Advanced Cash Flow Statement

Period Ending:

2014

31/12

2015

31/12

2016

31/12

2017

31/12

2018

31/12

2019

31/12

2020

31/12

2021

31/12

2022

31/12

2023

31/12

Cash from Operations

aa.aa

-10.73

-4.13

-8.58

-13.68

-17.12

	Cash from Operations Growth
	Net Income
	Depreciation & Amortisation, Total
	Amortisation of Deferred Charges, Total
	Other Non-Cash Items, Total
	Change in Net Operating Assets

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-257.14%	+61.5%	-107.82%	-59.42%	-25.13%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-6.04	-5.12	-8.37	-22.73	-16.55
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	0.32	0.23	0.15	0.14	0.17
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	0.55	0.73	-	-	-
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-3.1	-2.38	-2.86	8.31	0.3
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-2.44	2.4	2.5	0.6	-1.04

Cash from Investing

aa.aa

0.05

0.06

-0.66

-0.01

0.53

	Cash from Investing Growth
	Capital Expenditure
	Sale of Property, Plant, and Equipment
	Cash Acquisitions
	Divestitures
	Other Investing Activities

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	+242.86%	+12%	-1,275%	+98.18%	+4,500%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-0.03	-0.01	-0.02
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	0.01	0	-	-
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	0.05	0.05	-0.63	-0	0.55

Cash from Financing

aa.aa

3.89

20.47

51.04

-0.12

-0.15

	Cash from Financing Growth
	Total Debt Issued
	Short Term Debt Issued, Total
	Long-Term Debt Issued, Total
	Total Debt Repaid
	Short Term Debt Repaid, Total
	Long-Term Debt Repaid, Total
	Issuance of Common Stock
	Repurchase of Common Stock
	Issuance of Preferred Stock
	Repurchase of Preferred Stock
	Common & Preferred Stock Dividends Paid
	Special Dividend Paid
	Other Financing Activities
	Foreign Exchange Rate Adjustments
	Miscellaneous Cash Flow Adjustments

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	+425.76%	+149.35%	-100.23%	-27.97%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-0.61	-0.27	-0.13	-0.13	-0.15
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-0.61	-0.27	-0.13	-0.13	-0.15
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	1.85	23.5	54.29	-	-
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	2.66	-2.77	-3.12	0.02	-
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	0.11	0.04	-0.77	-0.88	0.15
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-

Net Change in Cash

aa.aa

-6.67

16.43

41.03

-14.69

-16.6

	Beginning Cash Balance
	Ending Cash Balance
	Levered Free Cash Flow
	Levered Free Cash Flow Growth
	Free Cash Flow Yield

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	14.51	7.84	24.27	65.3	50.61
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	7.84	24.27	65.3	50.61	34.02
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-5.96	-3.35	-4.75	-9.01	-10.21
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-204.3%	+43.79%	-41.86%	-89.46%	-13.34%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-

* In Millions of USD (except for per share items)

South Africa Top 40

74,294.01

+204.45

+0.28%

S. Africa 40 Futures

74,345.00

+167

+0.23%

US 30

41,192.00

+95.2

+0.23%

US 500

5,607.10

+11.3

+0.20%

US Tech 100

19,438.90

+12.9

+0.07%

DAX Futures

18,658.50

+138.5

+0.75%

Dollar Index

101.075

-0.276

-0.27%

Market Movers

Name	Last	Chg. %	Vol.
Sibanye Stillwater	1,659	+7.10%	1.50M
FirstRand Ltd	8,564	-0.63%	640.89K
Anglo American Platinum	54,483	+1.88%	68.33K
Anglo American	48,361	+0.81%	60.33K
Prosus	63,393	+0.05%	49.52K
AngloGold Ashanti ADR	49,930	+0.01%	43.20K
Naspers	350,100	-0.34%	15.82K

Name	Last	Chg. %	Vol.
Brikor	17.00	+21.43%	12.60K
Stefanutti Stocks	455	+18.18%	10.07K
Cilo Cybin Holdings	440.00	+10.00%	1.00K
Ayo Tech	50	0.00%	0.00
Sibanye Stillwater	1,659	+7.10%	1.50M
Murray & Roberts	288	+2.86%	51.11K
Impala Platinum	7,992	+3.36%	211.56K

Name	Last	Chg. %	Vol.
Mantengu Mining	85.00	-4.49%	66.90K
RENERGEN	1,001	-3.84%	2.17K
Purple Capital Ltd	77	-2.53%	869.00
Libstar	390	-2.50%	1.00
Mustek Ltd	1,251	-2.27%	1.00
Clicks	37,168	-1.94%	40.64K
RFG Holdings	1,530	-1.86%	1.72K

Trending Stocks

Name	Last	Chg. %	Vol.
Sibanye Stillwater	1,655	+6.84%	1.44M
Sasol	12,045	+0.63%	114.36K
Anglo American Platinum	54,252	+1.45%	64.88K
Harmony Gold Mining Company	17,174	+1.82%	77.44K
FirstRand Ltd	8,564	-0.63%	640.89K

Popular Searches

Please try another search

COSCIENS Biopharma Inc (0UGB)

0UGB Cash Flow Statement
Featured here, the Cash Flow Statement for COSCIENS Biopharma Inc, showing the changes in the company's cash and cash equivalents, broken down to operating, investing and financing activities over each of the last 10 periods (either quarterly or annually).

Trending Stocks

Please try another search

COSCIENS Biopharma Inc (0UGB)

0UGB Cash Flow StatementFeatured here, the Cash Flow Statement for COSCIENS Biopharma Inc, showing the changes in the company's cash and cash equivalents, broken down to operating, investing and financing activities over each of the last 10 periods (either quarterly or annually).

Trending Stocks

0UGB Cash Flow Statement
Featured here, the Cash Flow Statement for COSCIENS Biopharma Inc, showing the changes in the company's cash and cash equivalents, broken down to operating, investing and financing activities over each of the last 10 periods (either quarterly or annually).